The Current Ratio as of September 2024 (TTM) for Lantheus Holdings, Inc. (LNTH) is 4.68

According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.68. This represents a change of -9.58% compared to the average of 5.17 of the last 4 quarters.

Lantheus Holdings, Inc. (LNTH) Historical Current Ratio (quarterly & annually)

How has LNTH Current Ratio performed in the past?

The mean historical Current Ratio of Lantheus Holdings, Inc. over the last ten years is 2.96. The current 4.68 Current Ratio has changed 15.68% with respect to the historical average. Over the past ten years (40 quarters), LNTH's Current Ratio was at its highest in in the December 2023 quarter at 5.80. The Current Ratio was at its lowest in in the September 2014 quarter at 1.50.

Lantheus Holdings, Inc. (LNTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Lantheus Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lantheus Holdings, Inc. (LNTH) Average Current Ratio

How has LNTH Current Ratio performed in the past?

The current Current Ratio of Lantheus Holdings, Inc. (LNTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lantheus Holdings, Inc. (LNTH) Current Ratio vs. Peers

How is LNTH’s Current Ratio compared to its peers?

Lantheus Holdings, Inc.’s Current Ratio is greater than Neurocrine Biosciences, Inc. (4.19), greater than Deciphera Pharmaceuticals, Inc. (4.19), greater than Ironwood Pharmaceuticals, Inc. (3.92), greater than Alkermes plc (2.99), greater than Avadel Pharmaceuticals plc (2.82), less than ANI Pharmaceuticals, Inc. (0), greater than Dr. Reddy's Laboratories Limited (3.97), greater than Collegium Pharmaceutical, Inc. (2.55), greater than Pacira BioSciences, Inc. (1.11), less than Alvotech (6.82), greater than Catalent, Inc. (0.24), greater than Amphastar Pharmaceuticals, Inc. (2.52), greater than Journey Medical Corporation (3.52), greater than Aquestive Therapeutics, Inc. (1.36), less than Dynavax Technologies Corporation (7.49), less than null (14.18),

Build a custom stock screener for Lantheus Holdings, Inc. (LNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lantheus Holdings, Inc. (LNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.